Search Results - "del Val, Joaquin Hinojosa"
-
1
Old-age inflammatory bowel disease onset:A different problem
Published in World journal of gastroenterology : WJG (14-06-2011)“…Inflammatory bowel disease (IBD) in patients aged 60 accounts for 10%-15% of cases of the disease. Diganostic methods are the same as for other age groups…”
Get full text
Journal Article -
2
Clinical settings with tofacitinib in ulcerative colitis
Published in Revista española de enfermedades digestivas (01-09-2024)“…There are aspects of Janus kinase (JAK) inhibitors, specifically tofacitinib, that distinguish them from other drugs used in the treatment of ulcerative…”
Get full text
Journal Article -
3
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
Published in Revista española de enfermedades digestivas (01-05-2020)“…The purpose of this rapid review is to provide an update on the impact of SARS-CoV-2 infection on Gastroenterology and Hepatology departments, our patients,…”
Get full text
Journal Article -
4
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-06-2018)“…In 2013, the European Medicines Agency (EMA) approved the biosimilar infliximab (CT-P13) for the full range of indications of the originator product, based on…”
Get full text
Journal Article -
5
Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy
Published in Revista española de enfermedades digestivas (01-06-2023)“…Surgery in Crohn's disease may be the cause of short bowel syndrome that may lead to kidney dysfunction. Dual biologic therapy is rarely needed to control…”
Get full text
Journal Article -
6
Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab
Published in Gastroenterología y hepatología (01-12-2019)“…Vedolizumab is an anti-integrin monoclonal antibody indicated for the treatment of patients with moderately to severely active Crohn's disease and ulcerative…”
Get more information
Journal Article -
7
Author's answer to: "Effect of Adacolum[R] in ulcerative colitis with COVID-19"
Published in Revista española de enfermedades digestivas (01-06-2020)“…Keywords: Ulcerative colitis. Granulomonocytopheresis. COVID-19…”
Get full text
Journal Article -
8
Myiasis caused by Eristalis tenax in Crohn's disease
Published in Gastroenterología y hepatología (01-10-2010)Get more information
Journal Article -
9
Author´s answer to: "Effect of adacolumn® in ulcerative colitis with COVID-19"
Published in Revista española de enfermedades digestivas (01-06-2020)“…We have read with interest the article published by Pérez et al., we really appreciate their interesting comments and would like to qualify some points. With…”
Get full text
Journal Article -
10
-
11
Questions and answers about the management of Crohn’s disease and ulcerative colitis with vedolizumab
Published in Gastroenterología y Hepatología (English Edition) (01-12-2019)“…Vedolizumab is an anti-integrin monoclonal antibody indicated for the treatment of patients with moderately to severely active Crohn’s disease and ulcerative…”
Get full text
Journal Article -
12
Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy
Published in Gastroenterología y hepatología (01-06-2019)Get more information
Journal Article -
13
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
Published in Gastroenterología y Hepatología (English Edition) (01-05-2024)“…The treatment of inflammatory bowel disease has undergone a significant transformation following the introduction of biologic drugs. Thanks to these drugs,…”
Get full text
Journal Article -
14
Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy
Published in Gastroenterología y Hepatología (English Edition) (01-06-2019)Get full text
Journal Article -
15
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
Published in Revista española de enfermedades digestivas (01-06-2018)Get full text
Journal Article -
16
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel disease
Published in Revista española de enfermedades digestivas (2018)Get full text
Journal Article -
17
La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en España
Published in Revista española de salud pública (2019)“…Background: Immune-mediated inflammatory diseases (IMID) are chronic and highly disabling diseases that share inflammatory sequences and immunological…”
Get full text
Journal Article -
18
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Published in Reumatología clinica (Barcelona) (2010)“…The Spanish Society of Rheumatology (SER), through a multidiscipline task force, has elaborated a document with specific recommendations for specialists in…”
Get full text
Journal Article -
19
Recomendaciones de manejo de la gripe A (H1N1) en pacientes reumáticos con inmunosupresión
Published in Reumatología clinica (2010)“…Resumen La Sociedad Española de Reumatología (SER), a través de una comisión multidisciplinar, ha elaborado un documento con recomendaciones específicas para…”
Get full text
Journal Article